Concepedia

Anas Al-Janadi

AA

5

Publications

132

Citations

5

H-Index

2008

Active since

Affiliations

Michigan State University(Current)

National Cancer Institute

University of Wisconsin Carbone Cancer Center

Anas Al-Janadi is an author at Michigan State University specializing in neuro-oncology, dermatology, and surgical pathology.

ORCID

Top concepts

Publications per year

2008–2020

5

Publications

5

Cetuximab-Related Tumor Lysis Syndrome in Metastatic Colon Carcinoma

Krishnan Ganapathy, Karl J. D’Silva, Anas Al-Janadi · Journal of Clinical Oncology · 2008 · 43 citations · Full text

Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003

Arkadiusz Z. Dudek, Li Liu, Shilpa Gupta et al. · Journal of Clinical Oncology · 2020 · 42 citations · Full text

Rare Case of Hairy Cell Leukemia With Brain Parenchymal Involvement: A Diagnostic Dilemma

Sreenivasa R Chandana, Rupesh Kotecha, Anas Al-Janadi et al. · Journal of Clinical Oncology · 2013 · 17 citations · Full text

, , +5

BCNU toxicity presenting with a large pericardial and pleural effusion.

Ganapathy Subramaniam Krishnan, Vijay Chaudhary, Anas Al-Janadi et al. · PubMed · 2008 · 17 citations

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer

Elisabeth I. Heath, Lance K. Heilbrun, Heather D. Mannuel et al. · The Oncologist · 2019 · 13 citations · Full text

Rows per page

1–5 of 5